Abstract |
Vascular endothelial growth factor ( VEGF), also known as vascular permeability factor (VPF), is a key mediator of angiogenesis for both physiological and pathological conditions. It is well established that the hypoxic induction of VPF/ VEGF is in large part an increase in the stability of its mRNA. A Hu family ubiquitously expressed RNA-binding protein HuR has recently been shown to be important for VPF/ VEGF mRNA stabilization. In renal cancer cells, the inactivation of the tumor suppressor protein von Hippel Lindau (VHL) leads to an increase in VPF/ VEGF expression. VHL not only inhibits the transcription of VPF/ VEGF but also plays a significant role in decreasing its mRNA stability. Here we delineate a possible mechanism by which VHL can control the function of HuR in order to regulate the stability of VPF/ VEGF mRNA. The experiments presented here suggest that the association of the elongin-binding domain of VHL with a specific RNA-binding domain of HuR (RRM1) is important for the destabilizing function of VHL on VPF/ VEGF mRNA.
|
Authors | Kaustubh Datta, Susanta Mondal, Sutapa Sinha, Jinping Li, Enfeng Wang, Bertrand Knebelmann, S Ananth Karumanchi, Debabrata Mukhopadhyay |
Journal | Oncogene
(Oncogene)
Vol. 24
Issue 53
Pg. 7850-8
(Nov 24 2005)
ISSN: 0950-9232 [Print] England |
PMID | 16170373
(Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Elongin
- Transcription Factors
- Vascular Endothelial Growth Factors
- Von Hippel-Lindau Tumor Suppressor Protein
|
Topics |
- Carcinoma, Renal Cell
(genetics, physiopathology)
- Elongin
- Humans
- Kidney Neoplasms
(genetics, physiopathology)
- Neovascularization, Pathologic
- RNA Stability
- Transcription Factors
(metabolism)
- Tumor Cells, Cultured
- Vascular Endothelial Growth Factors
(biosynthesis)
- Von Hippel-Lindau Tumor Suppressor Protein
(physiology)
|